Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UNITED THERAPEUTICS Corp Director's Dealing 2016

Aug 5, 2016

30320_dirs_2016-08-05_7b60608b-3515-4530-b9a4-f09c1f8b591b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2016-08-04

Reporting Person: MAHON PAUL A (EVP & General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-08-04 Common Stock M 6000 $50.09 Acquired 41221 Direct
2016-08-04 Common Stock D 6000 $125.48 Disposed 35221 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-08-04 Share Tracking Award $50.09 M 6000 Disposed 2019-09-15 Common Stock (6000) Direct

Footnotes

F1: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.